Latest middle-of-the-night insomnia Stories

People with insomnia may now have one more thing to keep them up at night: an increased likelihood of developing hypertension, according to a study from Henry Ford Hospital in Detroit. Researchers at the Henry Ford Center for Sleep Disorders found that the prevalence of hypertension was greater in insomniacs compared to normal sleepers. "The cause of hypertension in insomniacs is due to the number of times the individual wakes during the night as well as their sleep latency – the...

POINT RICHMOND, Calif., Nov. 30, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that Purdue has exercised its option to commercialize Intermezzo® in the United States. Purdue plans to launch Intermezzo in the second quarter of 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization. On November 23, 2011, the U.S. Food Drug Administration (FDA) approved Intermezzo®...

Point Richmond, Calif., Nov. 23, 2011 /PRNewswire/ --Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that the U.S. Food and Drug Administration (FDA) has approved Intermezzo® (zolpidem tartrate sublingual tablet)( )C-IV for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. Intermezzo is not indicated for the treatment of middle-of-the-night insomnia when the patient has fewer than 4...

BGU Research Supports the Hypothesis that Patients Thought to Have Nocturic Episodes (Waking-up from the Need to Void) Actually Wake from Apnea and THEN Decide to UrinateBen-Gurion University of the Negev (BGU) researchers have shown that a significant number of patients with benign prostate enlargement (BPE) may have Obstructive Sleep Apnea (OSA), which may be the reason for their night awakenings and urination.This study compared men between the ages of 55 and 75 years-old, who were...

U.S. researchers suggest some military personnel could benefit from treatment for sleep disturbances. Dr. Taylor Plumb and Dr. Diane Zelman of the California School of Professional Psychology at Alliant International University found high rates of disturbed sleep among 375 current and former military personnel who served in Afghanistan during Operation Enduring Freedom or Iraq during Operation Iraqi Freedom. Even many months following deployment, 56.3 percent of participants reported sleep...

RICHMOND, Calif., July 22 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Glenn A. Oclassen, President & Chief Executive Officer, is scheduled to present at the BMO Capital Markets Healthcare Conference in New York City on Wednesday, August 5, 2009 at 4:00 p.m.,...

Analyses of Efficacy and Absence of Rebound Effect in a Clinical Study of Intermezzo(R) (Zolpidem Tartrate Sublingual Tablet 3.5 mg) to Treat Middle-of-the-Night (MOTN) Awakening on an As-Needed Basis RICHMOND, Calif., June 9 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today...

PT. RICHMOND, Calif., Oct. 22 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that a Phase 3 study evaluating the safety and efficacy of its lead product candidate, Intermezzo(R) (zolpidem tartrate sublingual lozenge), has been published in the September 2008 issue of SLEEP, a publication of the Associated Professional Sleep Societies. Intermezzo(R) is a low dose, buffered, sublingual formulation of zolpidem intended to be...

Two new studies show that insomnia, far from being a symptom or side effect of depression, may instead precede it, making some patients more likely to become and remain mentally ill. One paper was presented today at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS) in Denver, and the other will be published shortly in the Journal of Behavioral Sleep Medicine. In recent years, researchers established that insomnia and depression are linked, but struggled to...